IQVIA Holdings stock fell 0.86 percent before Q3 results

Published on 10/04/2026 at 17:41 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

IQVIA Holdings stock heads into its October 27 report after Q2 adjusted EPS reached USD 3.15. R&D bookings rose 19 percent to USD 3.2 billion, while analysts set an average target of USD 264.31.

NYSE Trading Floor mit aktiven Tradern und Healthcare-Sektor-Indexcharts auf Digitalanzeigen — IQVIA Holdings NYSE Börsenparkett US46266C1053 mit aktiven Tradern und Healthcare Sektor Indexcharts auf digitalen Anzeigetafeln, Illustration mit AI erstellt.

IQVIA Holdings stock (ISIN US46266C1053) fell 0.86 percent to USD 258.48 on the NYSE on October 2, 2026, setting a cautious market tone before the next earnings checkpoint. MarketBeat lists IQVIA's third-quarter report for October 27, 2026, before the market opens. The date gives investors a defined test for whether the company's second-quarter acceleration can continue.

Second-quarter growth sets the benchmark

According to Zacks on October 2, 2026, IQVIA's second-quarter 2026 adjusted EPS rose 12.1 percent year over year to USD 3.15. The figure exceeded the USD 3.02 consensus cited by Zacks by USD 0.13, or 4.3 percent.

Revenue increased 8.7 percent year over year to USD 4.37 billion and exceeded the USD 4.29 billion consensus by 1.9 percent. The combination matters because revenue growth was accompanied by a larger adjusted earnings gain, giving the October report a clear operating benchmark.

Bookings and cash flow carry the story

IQVIA's Research and Development Solutions segment recorded USD 3.2 billion in net new bookings in Q2 2026, up 19 percent year over year, while trailing-12-month bookings reached USD 11.3 billion, according to Zacks. Those figures point to demand visibility beyond one quarter, although the balance sheet remains an important counterweight.

Operating cash flow rose 26 percent year over year to USD 558 million in Q2 2026, while free cash flow increased 23.3 percent to USD 360 million. Zacks also reported USD 14.1 billion in net debt and net leverage of 3.6 times adjusted EBITDA, which keeps financing and execution central to the next results discussion.

Analysts see limited upside

MarketBeat reported on October 1, 2026, that UBS upgraded IQVIA to Strong Buy. The same report cited a Moderate Buy consensus and an average price target of USD 264.31 from 17 firms.

That average target lies 2.3 percent above the October 2 closing price of USD 258.48. For investors, the next earnings release must therefore do more than repeat the Q2 beat: it must support the bookings trend and the full-year adjusted EPS guidance of USD 12.80 to USD 13.00 reported by MarketBeat.

IQVIA Holdings stock stays below its yearly high

IQVIA Holdings stock closed at USD 258.48 on the NYSE on October 2, 2026. Its 52-week range was USD 154.50 to USD 277.40, and its market capitalization was USD 42.5 billion on the same date.